Kai Lyn Goh BOptom, PhD, Carla J. Abbott BOptom, PhD, Thomas G. Campbell DPhil, FRANZCO, Amy C. Cohn MMed, FRANZCO, Dai Ni Ong BMedSc(Hons), FRANZCO, Sanjeewa S. Wickremasinghe DMSc, FRANZCO, Lauren A. B. Hodgson MPH, Robyn H. Guymer PhD, FRANZCO, Zhichao Wu BAppSc(Optom), PhD
{"title":"利用多模态成像预测晚期老年性黄斑变性发展的临床表现。","authors":"Kai Lyn Goh BOptom, PhD, Carla J. Abbott BOptom, PhD, Thomas G. Campbell DPhil, FRANZCO, Amy C. Cohn MMed, FRANZCO, Dai Ni Ong BMedSc(Hons), FRANZCO, Sanjeewa S. Wickremasinghe DMSc, FRANZCO, Lauren A. B. Hodgson MPH, Robyn H. Guymer PhD, FRANZCO, Zhichao Wu BAppSc(Optom), PhD","doi":"10.1111/ceo.14405","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>To examine whether the clinical performance of predicting late age-related macular degeneration (AMD) development is improved through using multimodal imaging (MMI) compared to using colour fundus photography (CFP) alone, and how this compares with a basic prediction model using well-established AMD risk factors.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Individuals with AMD in this study underwent MMI, including optical coherence tomography (OCT), fundus autofluorescence, near-infrared reflectance and CFP at baseline, and then at 6-monthly intervals for 3-years to determine MMI-defined late AMD development. Four retinal specialists independently assessed the likelihood that each eye at baseline would progress to MMI-defined late AMD over 3-years with CFP, and then with MMI. Predictive performance with CFP and MMI were compared to each other, and to a basic prediction model using age, presence of pigmentary abnormalities, and OCT-based drusen volume.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The predictive performance of the clinicians using CFP [AUC = 0.75; 95% confidence interval (CI) = 0.68–0.82] improved when using MMI (AUC = 0.79; 95% CI = 0.72–0.85; <i>p</i> = 0.034). However, a basic prediction model outperformed clinicians using either CFP or MMI (AUC = 0.85; 95% CI = 0.78–91; <i>p</i> ≤ 0.002).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Clinical performance for predicting late AMD development was improved by using MMI compared to CFP. However, a basic prediction model using well-established AMD risk factors outperformed retinal specialists, suggesting that such a model could further improve personalised counselling and monitoring of individuals with the early stages of AMD in clinical practice.</p>\n </section>\n </div>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":"52 7","pages":"774-782"},"PeriodicalIF":4.9000,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ceo.14405","citationCount":"0","resultStr":"{\"title\":\"Clinical performance of predicting late age-related macular degeneration development using multimodal imaging\",\"authors\":\"Kai Lyn Goh BOptom, PhD, Carla J. Abbott BOptom, PhD, Thomas G. Campbell DPhil, FRANZCO, Amy C. Cohn MMed, FRANZCO, Dai Ni Ong BMedSc(Hons), FRANZCO, Sanjeewa S. Wickremasinghe DMSc, FRANZCO, Lauren A. B. Hodgson MPH, Robyn H. Guymer PhD, FRANZCO, Zhichao Wu BAppSc(Optom), PhD\",\"doi\":\"10.1111/ceo.14405\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>To examine whether the clinical performance of predicting late age-related macular degeneration (AMD) development is improved through using multimodal imaging (MMI) compared to using colour fundus photography (CFP) alone, and how this compares with a basic prediction model using well-established AMD risk factors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Individuals with AMD in this study underwent MMI, including optical coherence tomography (OCT), fundus autofluorescence, near-infrared reflectance and CFP at baseline, and then at 6-monthly intervals for 3-years to determine MMI-defined late AMD development. Four retinal specialists independently assessed the likelihood that each eye at baseline would progress to MMI-defined late AMD over 3-years with CFP, and then with MMI. Predictive performance with CFP and MMI were compared to each other, and to a basic prediction model using age, presence of pigmentary abnormalities, and OCT-based drusen volume.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The predictive performance of the clinicians using CFP [AUC = 0.75; 95% confidence interval (CI) = 0.68–0.82] improved when using MMI (AUC = 0.79; 95% CI = 0.72–0.85; <i>p</i> = 0.034). However, a basic prediction model outperformed clinicians using either CFP or MMI (AUC = 0.85; 95% CI = 0.78–91; <i>p</i> ≤ 0.002).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Clinical performance for predicting late AMD development was improved by using MMI compared to CFP. However, a basic prediction model using well-established AMD risk factors outperformed retinal specialists, suggesting that such a model could further improve personalised counselling and monitoring of individuals with the early stages of AMD in clinical practice.</p>\\n </section>\\n </div>\",\"PeriodicalId\":55253,\"journal\":{\"name\":\"Clinical and Experimental Ophthalmology\",\"volume\":\"52 7\",\"pages\":\"774-782\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2024-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ceo.14405\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ceo.14405\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ceo.14405","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Clinical performance of predicting late age-related macular degeneration development using multimodal imaging
Background
To examine whether the clinical performance of predicting late age-related macular degeneration (AMD) development is improved through using multimodal imaging (MMI) compared to using colour fundus photography (CFP) alone, and how this compares with a basic prediction model using well-established AMD risk factors.
Methods
Individuals with AMD in this study underwent MMI, including optical coherence tomography (OCT), fundus autofluorescence, near-infrared reflectance and CFP at baseline, and then at 6-monthly intervals for 3-years to determine MMI-defined late AMD development. Four retinal specialists independently assessed the likelihood that each eye at baseline would progress to MMI-defined late AMD over 3-years with CFP, and then with MMI. Predictive performance with CFP and MMI were compared to each other, and to a basic prediction model using age, presence of pigmentary abnormalities, and OCT-based drusen volume.
Results
The predictive performance of the clinicians using CFP [AUC = 0.75; 95% confidence interval (CI) = 0.68–0.82] improved when using MMI (AUC = 0.79; 95% CI = 0.72–0.85; p = 0.034). However, a basic prediction model outperformed clinicians using either CFP or MMI (AUC = 0.85; 95% CI = 0.78–91; p ≤ 0.002).
Conclusions
Clinical performance for predicting late AMD development was improved by using MMI compared to CFP. However, a basic prediction model using well-established AMD risk factors outperformed retinal specialists, suggesting that such a model could further improve personalised counselling and monitoring of individuals with the early stages of AMD in clinical practice.
期刊介绍:
Clinical & Experimental Ophthalmology is the official journal of The Royal Australian and New Zealand College of Ophthalmologists. The journal publishes peer-reviewed original research and reviews dealing with all aspects of clinical practice and research which are international in scope and application. CEO recognises the importance of collaborative research and welcomes papers that have a direct influence on ophthalmic practice but are not unique to ophthalmology.